NINGBO INNO PHARMCHEM CO.,LTD. is pleased to announce the availability of a key pharmaceutical intermediate, N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7-[(4-Methylphenyl)Sulfonyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine, widely recognized by its CAS number 923036-30-0. This compound serves as a vital building block in the synthesis of Tofacitinib Citrate, a prominent active pharmaceutical ingredient (API).
Tofacitinib Citrate is known for its application as a Janus kinase (JAK) inhibitor, prescribed for various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The purity and consistency of its intermediates are paramount to ensuring the efficacy and safety of the final drug product.
Our Intermediate for Tofacitinib Citrate (CAS 923036-30-0) is manufactured under strict quality control measures to meet the demanding requirements of the pharmaceutical industry. It is supplied as a fine powder, suitable for synthesis processes. We understand the critical nature of sourcing reliable and high-purity intermediates for API production and are committed to providing materials that adhere to stringent quality standards.
The physical properties of this intermediate are well-characterized, including a melting point typically ranging from 180 to 183ºC. Its chemical formula is C27H31N5O2S. Such precise specifications ensure its suitability and predictability in complex chemical synthesis pathways, contributing to efficient and reproducible manufacturing of Tofacitinib Citrate.
By offering this essential intermediate, NINGBO INNO PHARMCHEM CO.,LTD. supports pharmaceutical companies globally in their drug development and production efforts. Our focus on quality, coupled with a reliable supply chain, makes us a trusted partner for your intermediate needs. We are dedicated to facilitating the progress of pharmaceutical research and development by providing the necessary high-quality chemical components.
For pharmaceutical manufacturers and researchers requiring the Tofacitinib Citrate intermediate CAS 923036-30-0, NINGBO INNO PHARMCHEM CO.,LTD. is ready to assist. We welcome inquiries regarding detailed product specifications, sample requests, and supply capabilities. As a specialized manufacturer and supplier, we offer competitive pricing and reliable logistics to support your procurement process. If you are looking to buy or purchase this essential intermediate powder, please contact us directly to discuss your requirements and obtain a quotation for the Tofacitinib Citrate intermediate CAS 923036-30-0 price.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.